MYGN. Myriad Genetics' Prolaris Test Predicts Biochemical Recurrence in Prostate Cancer Patients Following Radiation Therapy http://finance.yahoo.com/news/myriad-genetics-prolaris-test-predicts-211000796.html http://stockcharts.com/c-sc/sc?s=MYGN&p=D&yr=0&mn=5&dy=0&i=t27250769470&r=1354137154952